Robert E Landry Net Worth & Insider Trades

Robert E Landry - EVP Finance CFO, Regeneron Pharmaceuticals, Inc

As of December 2, 2022

What is Robert E Landry's Net Worth?

The current estimated net worth of Regeneron Pharmaceuticals, Inc's EVP Finance CFO, Robert E Landry, is estimated to be about $36.18M . Robert E Landry owns about 28,994 units of Regeneron Pharmaceuticals, Inc common stock. In the last 9 years at Regeneron Pharmaceuticals, Inc, Robert E Landry has sold an estimated value of $97.64M worth.

What is Robert E Landry's Past Insider Trading?

Robert E Landry's largest purchase order was 12,500 units , worth over $6.56M on July 9, 2020. Robert E Landry's largest sale order was 14,500 units , worth over $9.94M on March 30, 2022. In total, Robert E Landry has made about 45 transactions over 9 years of their time at Regeneron Pharmaceuticals, Inc. Robert E Landry usually trades in December, with the busiest year in 2020. The most recent transaction was a sale order of 2,500 units , worth over $1.9M on December 2, 2022.

Robert E Landry

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Robert E Landry's Salary in 2020?

As EVP Finance CFO of Regeneron Pharmaceuticals, Inc, Robert E Landry has a total base salary of $825,577 . Robert E Landry received compensation valued at about $6,197,703 in 2020 after becoming EVP Finance CFO. The vast majority of their compensation came in the form of stock awards of $949,560 , other earnings, plans or compensations of $938,872 , other earnings, plans or compensations of $938,872 , and other compensation of $24,195 .

What is Robert E Landry's' Mailing Address?

  • Mailing address is 777 Old Saw Mill River Road Tarrytown NY 10591 NY

Regeneron Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Leonard S. Schleifer, M.D., Ph.D. 2020 $1,480,119 $130,000,032 $3,567,714 $3,567,714 $302,256 $135,350,121
Leonard S. Schleifer, M.D., Ph.D. 2019 $1,377,100 $4,983,226 $3,057,162 $3,057,162 $338,043 $21,455,117
Leonard S. Schleifer, M.D., Ph.D. 2018 $1,330,500 - $2,953,710 $2,953,710 $896,432 $26,520,555
George D. Yancopoulos, M.D., Ph.D. 2020 $1,258,096 $130,000,032 $3,004,391 $3,004,391 $120,800 $134,383,319
George D. Yancopoulos, M.D., Ph.D. 2019 $1,170,500 $4,983,226 $2,598,510 $2,598,510 $212,313 $20,664,135
George D. Yancopoulos, M.D., Ph.D. 2018 $1,130,900 - $2,510,598 $2,510,598 $399,718 $25,381,129
Robert E. Landry 2020 $825,577 $949,560 $938,872 $938,872 $24,195 $6,197,703
Robert E. Landry 2019 $730,000 $2,840,008 $811,395 $811,395 $23,470 $7,931,542
Robert E. Landry 2018 $680,000 $4,767,500 $581,400 $581,400 $19,535 $9,356,619
Daniel P. Van Plew 2020 $825,577 $3,409,560 $938,872 $938,872 $20,945 $8,654,453
Daniel P. Van Plew 2019 $683,100 $2,840,008 $759,266 $759,266 $20,470 $7,829,513
Daniel P. Van Plew 2018 $660,000 - $677,160 $677,160 $19,915 $9,007,222
Andrew J. Murphy, Ph.D. 2020 $726,923 $5,025,288 $887,250 $887,250 $24,195 $10,998,914
Andrew J. Murphy, Ph.D. 2019 $600,000 $4,702,308 $666,900 $666,900 $23,470 $9,519,347
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/872589/000093041321000869/c101011_def14a.htm

What are Regeneron Pharmaceuticals, Inc's Past Insider Trades?

Regeneron Pharmaceuticals, Inc's most recent insider trade came on December 2, 2022 by Arthur F Ryan who sold 100 units worth $75.82K . In the last 19 years, insiders at Regeneron Pharmaceuticals, Inc have sold an estimated value of $17.48B and bought an estimated value of $3.51B worth of shares. Insider trading is most common in December, with the busiest year in 2014. The most active traders at the company are Joseph L Goldstein, Director,  Michael S Brown, Director,  and P. Roy Vagelos, Director .

REGENERON PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1